Product
vudalimab
1 clinical trial
5 indications
Indication
Ovarian CancerIndication
Clear Cell CarcinomaIndication
Endometrial CancerIndication
Cervical CancerClinical trial
A Phase 2 Study of XmAb20717 in Patients With Selected Gynecological Malignancies and High-Risk Metastatic Castration-Resistant Prostate CancerStatus: Recruiting, Estimated PCD: 2025-03-15